UK Government pledges funds for 2019-nCoV vaccine research

  • Department of Health and Social Care
  • 3 Feb 2020

  • curated by Pavankumar Kamat
  • UK Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

The UK Government has pledged £20 million to help develop new vaccines against the world's deadliest infectious diseases, including the ongoing 2019 novel coronavirus (2019-nCoV) outbreak.

The funding will be directed to the Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership between public, private, philanthropic, and civil society organisations which was inaugurated in Davos in 2017, with a key focus on vaccine development.

The new funding will support research and development work for new vaccines, including three new programmes to develop vaccines against the 2019-nCoV. The projects aim to push 2019-nCoV vaccine candidates into trials at the earliest. The CEPI is expecting 16 weeks for a vaccine candidate to move from the pathogen gene sequencing stage to clinical testing, and two to four months for the phase 1 clinical trials.

Additionally, the Government is in early stages of discussions between the National Institute for Health Research and the UK Research and Innovation regarding plans to implement a rapid research call as a part of the global response to 2019-nCoV.

Dr Richard Hatchett, Chief Executive Officer of CEPI, said: "CEPI welcomes the UK’s continued support and funding for our vital work, which comes at a crucial moment as the world races to respond to the emergence of a novel coronavirus."